Invacare Shares Outstanding 2006-2019 | IVC

Invacare shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Invacare Annual Shares Outstanding
(Millions of Shares)
2019 34
2018 34
2017 33
2016 33
2015 33
2014 32
2013 32
2012 32
2011 32
2010 33
2009 32
2008 32
2007 32
2006 32
2005 32
Invacare Quarterly Shares Outstanding
(Millions of Shares)
2019-12-31 34
2019-09-30 34
2019-06-30 34
2019-03-31 33
2018-12-31 34
2018-09-30 34
2018-06-30 34
2018-03-31 34
2017-12-31 33
2017-09-30 33
2017-06-30 33
2017-03-31 33
2016-12-31 33
2016-09-30 33
2016-06-30 33
2016-03-31 33
2015-12-31 33
2015-09-30 33
2015-06-30 33
2015-03-31 32
2014-12-31 32
2014-09-30 32
2014-06-30 32
2014-03-31 32
2013-12-31 32
2013-09-30 32
2013-06-30 32
2013-03-31 32
2012-12-31 32
2012-09-30 32
2012-06-30 32
2012-03-31 32
2011-12-31 32
2011-09-30 32
2011-06-30 33
2011-03-31 33
2010-12-31 33
2010-09-30 33
2010-06-30 32
2010-03-31 33
2009-12-31 32
2009-09-30 32
2009-06-30 32
2009-03-31 32
2008-12-31 32
2008-09-30 32
2008-06-30 32
2008-03-31 32
2007-12-31 32
2007-09-30 32
2007-06-30 32
2007-03-31 32
2006-12-31 32
2006-09-30 32
2006-06-30 32
2006-03-31 32
2005-12-31 32
2005-09-30 32
2005-06-30 33
2005-03-31 33
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.252B $0.928B
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $62.307B 19.76
McKesson (MCK) United States $23.932B 9.39
AmerisourceBergen (ABC) United States $18.221B 12.22
Cooper (COO) United States $14.702B 22.67
Cardinal Health (CAH) United States $13.988B 8.73
Align Technology (ALGN) United States $13.699B 35.07
Laboratory Of America Holdings (LH) United States $12.298B 11.18
Straumann Holding AG (SAUHF) Switzerland $11.784B 0.00
West Pharmaceutical Services (WST) United States $11.243B 46.99
DENTSPLY SIRONA (XRAY) United States $8.598B 15.85
Henry Schein (HSIC) United States $7.244B 14.39
SmileDirectClub (SDC) United States $1.795B 0.00
Merit Medical Systems (MMSI) United States $1.726B 21.26
CONMED (CNMD) United States $1.632B 21.61
Patterson (PDCO) United States $1.465B 10.19
STAAR Surgical (STAA) United States $1.451B 67.21
Atrion (ATRI) United States $1.206B 32.94
Antares Pharma (ATRS) United States $0.391B 0.00
Lifevantage (LFVN) United States $0.147B 12.41
Pro-Dex (PDEX) United States $0.063B 16.88
Milestone Scientific (MLSS) United States $0.061B 0.00
Retractable Technologies (RVP) United States $0.051B 19.50
Endologix (ELGX) United States $0.013B 0.00
Biolase (BIOL) United States $0.012B 0.00